海辰藥業(300584.SZ):2580萬元競得合肥東部新城核心區一宗工業用地
格隆匯5月28日丨海辰藥業(300584.SZ)公佈,全資子公司安徽海辰於近日參與了肥東縣FDG20-10地塊土地使用權的競拍,並最終以人民幣2580萬元競得該宗土地的使用權。2020年5月25日,安徽海辰與肥東縣自然資源和規劃局簽署了《國有建設用地使用權出讓合同》。
宗地編號:FDG20-10;宗地位置:合肥東部新城核心區醉翁路與峯迴路交口東南側;宗地面積:12萬平方米;宗地用途:工業用地;出讓年限:50年;成交價格:人民幣2580萬元。
安徽海辰此次受讓取得土地主要用於公司肥東產研基地項目的發展建設用地,滿足公司肥東醫藥生產基地後期建設廠房、辦公生產及生活配套設施等的場地需求。肥東產研基地項目有利於進一步推動公司生產基地的區域合理佈局,提升公司產品層次,合理調配各生產基地產能,有效合理降低經營成本,發揮產品資源整合優勢和生產效益,提升企業綜合競爭實力,為公司未來產品多元化及長遠發展打下堅實基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.